$17.43
0.281.63%
Last update: Oct 23, 4:46 PM
Tandem Diabetes Care Inc (TNDM) Stock Price, Quote, News & History
TNDMNASDAQ
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.
You can purchase shares of Tandem Diabetes Care (NASDAQ:TNDM) through any online brokerage.
Other companies in Tandem Diabetes Care’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Tandem Diabetes Care has a consensus price target of $28.56.
The stock price for Tandem Diabetes Care (NASDAQ: TNDM) is $17.3548 last updated October 23, 2026 at 4:46 PM EDT.
There are no upcoming dividends for Tandem Diabetes Care.
Tandem Diabetes Care does not have any upcoming earnings scheduled.
There is no upcoming split for Tandem Diabetes Care.
Tandem Diabetes Care is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The...
